Compounded Tirzepatide Oral Dissolving Tablets

Tirzepatide is a dual-pathway medication that targets GLP-1 and GIP receptor signaling¹ — two hormone pathways involved in appetite regulation and blood sugar control. In a clinician-guided program it may help support appetite regulation and fullness for some people.³ The oral dissolving tablet delivers the same molecule as the injection in a once-daily tablet you dissolve under your tongue.

Adults a licensed provider determines are clinically appropriate after reviewing your health history. Eligibility is decided by the provider, not by us — not everyone qualifies, and tirzepatide is not right for everyone.

If the provider decides treatment is not appropriate for you, there is nothing to pay.

One monthly price covering the medication itself, your provider review and prescription, discreet shipping, and ongoing access to the clinical team. No separate medication charge and no hidden fees.

To get started, complete an online intake about your health history and goals. A licensed provider reviews it and prescribes if appropriate. Refills and dose adjustments are coordinated with your care team.

One tablet a day, dissolved under the tongue rather than swallowed. Your provider starts you at a low dose and steps it up gradually to limit side effects.

• Once-daily tablet Tirzepatide oral dissolving tablets are taken once a day — no needles and no water needed. Many people take theirs in the morning.
• Dissolve under the tongue With clean, dry hands, place the tablet under your tongue and let it dissolve completely — usually under a minute. Do not chew it or swallow it whole.
• Gradual dose titration Your provider starts you at a low dose and increases gradually over the first weeks to minimize side effects.
• Missed dose guidance If you remember the same day, take it as soon as you remember. If you do not remember until the next day, skip the missed dose and take your next one at the usual time. Never take two doses in one day. When in doubt, message your care team before dosing.

Most people tolerate treatment well, and side effects are usually most noticeable in the first few weeks. Your provider helps you manage them and adjusts your plan if needed.

• Common side effects Nausea, fatigue, decreased appetite, occasional diarrhea or constipation — most pronounced during the first 2–4 weeks.¹
• When they subside For most people, side effects ease as your body adjusts to the medication and at stable dose levels.
• When to contact your provider Severe abdominal pain, signs of allergic reaction, vision changes, or persistent vomiting require immediate provider contact.
• Not for everyone Tirzepatide is not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2.¹

Your tablets ship in a sealed container and stay at room temperature — no refrigeration, but they do need to stay dry.

• Room temperature Store at 68–77°F (20–25°C) in a cool, dry place. No refrigeration needed.
• Keep them dry Keep tablets in their original container with the lid closed, and handle them with dry hands. Moisture can start breaking a dissolving tablet down before you take it.
• Handle the packaging carefully Peel the foil back to remove a tablet rather than pushing the tablet through it, which can damage the tablet.
• Travel guidance Room-temperature storage makes travel straightforward — keep the container sealed and out of direct heat and sunlight. No cooler needed.